Philip J. Clements

25.2k total citations · 2 hit papers
174 papers, 9.0k citations indexed

About

Philip J. Clements is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Philip J. Clements has authored 174 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pathology and Forensic Medicine, 68 papers in Pulmonary and Respiratory Medicine and 37 papers in Epidemiology. Recurrent topics in Philip J. Clements's work include Systemic Sclerosis and Related Diseases (119 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (56 papers) and Inflammatory Myopathies and Dermatomyositis (35 papers). Philip J. Clements is often cited by papers focused on Systemic Sclerosis and Related Diseases (119 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (56 papers) and Inflammatory Myopathies and Dermatomyositis (35 papers). Philip J. Clements collaborates with scholars based in United States, United Kingdom and Canada. Philip J. Clements's co-authors include Daniel E. Furst, Dinesh Khanna, Daniel E. Fürst, Donald P. Tashkin, Harold E. Paulus, Maureen D. Mayes, Peter A. Lachenbruch, Michael D. Roth, James R. Seibold and David Tak Yan Yu and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Philip J. Clements

170 papers receiving 8.6k citations

Hit Papers

Inter and intraobserver variability of total skin thickne... 1995 2026 2005 2015 1995 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
    1995 711 citations Philip J. Clements, Barbara White et al. PubMed profile →
  2. Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
    2017 320 citations Dinesh Khanna, Daniel E. Furst et al. Journal of Scleroderma and Related Disorders profile →

Peers

Philip J. Clements
Murray Baron Canada
Fredrick M. Wigley United States
Marie Hudson Canada
Maureen D. Mayes United States
Frank A. Wollheim Sweden
Luc Mouthon France
Virginia Steen United States
F.H.J. van den Hoogen Netherlands
Roberto Giacomelli Italy
Giuseppe Rossi Italy
Murray Baron Canada
Philip J. Clements
Citations per year, relative to Philip J. Clements Philip J. Clements (= 1×) peers Murray Baron

Countries citing papers authored by Philip J. Clements

Since Specialization
Citations

This map shows the geographic impact of Philip J. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Clements more than expected).

Fields of papers citing papers by Philip J. Clements

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Clements. The network helps show where Philip J. Clements may publish in the future.

Co-authorship network of co-authors of Philip J. Clements

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Clements. A scholar is included among the top collaborators of Philip J. Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Clements. Philip J. Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roesch, Scott C., et al.. (2020). Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approach. Journal of Scleroderma and Related Disorders. 5(3). 231–236. 4 indexed citations
2.
Kafaja, Suzanne, Philip J. Clements, Holly Wilhalme, et al.. (2017). Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II). American Journal of Respiratory and Critical Care Medicine. 197(5). 644–652. 86 indexed citations
3.
Kafaja, Suzanne & Philip J. Clements. (2016). Management of Widespread Skin Thickening in Diffuse Systemic Sclerosis. PubMed. 2(1). 49–60. 4 indexed citations
4.
Tashkin, Donald P., Michael D. Roth, Philip J. Clements, et al.. (2015). Efficacy and Safety of Mycophenolate (MMF) Vs Oral Cyclophosphamide (CYC) for Treatment of Scleroderma-Interstitial Lung Disease (Ssc-ILD): Results of Scleroderma Lung Study II. CHEST Journal. 148(4). 637A–637A. 4 indexed citations
5.
Avouac, Jérôme, et al.. (2012). Articular involvement in systemic sclerosis. Lara D. Veeken. 51(8). 1347–1356. 65 indexed citations
6.
Clements, Philip J., Mary Tan, Vallerie V. McLaughlin, et al.. (2011). The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Annals of the Rheumatic Diseases. 71(2). 249–252. 54 indexed citations
7.
McLaughlin, Vallerie V., Anatoly Langer, Amparo Casanova, et al.. (2010). Contemporary Trends in the Diagnosis and Management of PAH: An Initiative To Close the Care Gap. CHEST Journal. 138(4). 351A–351A. 2 indexed citations
8.
9.
Saggar, Rajeev, Dhanita Khanna, Daniel E. Furst, et al.. (2010). Systemic sclerosis and bilateral lung transplantation: a single centre experience. European Respiratory Journal. 36(4). 893–900. 66 indexed citations
10.
Hays, Ron D., Paul Maranian, Daniel E. Fürst, et al.. (2010). Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Lara D. Veeken. 50(2). 330–334. 65 indexed citations
11.
Braun‐Moscovici, Yolanda, Daniel E. Furst, Doron Markovits, et al.. (2008). Vitamin D, Parathyroid Hormone, and Acroosteolysis in Systemic Sclerosis. The Journal of Rheumatology. 35(11). 2201–2205. 51 indexed citations
12.
13.
Strange, Charlie, Marcy B. Bolster, Michael D. Roth, et al.. (2007). Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 177(1). 91–98. 92 indexed citations
14.
Khanna, Dinesh, Daniel E. Fürst, Weng Kee Wong, et al.. (2007). Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis. Quality of Life Research. 16(6). 1083–1092. 47 indexed citations
15.
Cole, Jason C., Dinesh Khanna, Philip J. Clements, et al.. (2006). Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients. Quality of Life Research. 15(8). 1383–1394. 23 indexed citations
16.
Clements, Philip J.. (2000). Systemic sclerosis (scleroderma) and related disorders: clinical aspects. Best Practice & Research Clinical Rheumatology. 14(1). 1–16. 44 indexed citations
17.
Clegg, Daniel O., James C. Reading, Maureen D. Mayes, et al.. (1994). Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.. PubMed. 21(1). 105–10. 13 indexed citations
18.
Sargan, David R., et al.. (1994). Progressive retinal atrophy: a model for retinitis pigmentosa in companion animals.. PubMed. 1 Suppl 1(9). S89–S89. 7 indexed citations
19.
Ng, Swee Cheng, et al.. (1989). Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis & Rheumatism. 32(2). 212–216. 31 indexed citations
20.
Yu, David Tak Yan, Philip J. Clements, Harold E. Paulus, et al.. (1974). Human lymphocyte subpopulations. Effect of corticosteroids.. Journal of Clinical Investigation. 53(2). 565–571. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murray Baron Breakdown of academic impact, for papers by Fredrick M. Wigley Breakdown of academic impact, for papers by Marie Hudson Breakdown of academic impact, for papers by Maureen D. Mayes Breakdown of academic impact, for papers by Frank A. Wollheim Breakdown of academic impact, for papers by Luc Mouthon Breakdown of academic impact, for papers by Virginia Steen Breakdown of academic impact, for papers by F.H.J. van den Hoogen Breakdown of academic impact, for papers by Roberto Giacomelli Breakdown of academic impact, for papers by Giuseppe Rossi
Rankless by CCL
2026